Assessment of office-based care of sexually transmitted diseases and vaginitis and antibiotic decision-making by obstetrician-gynecologists

Infectious Diseases in Obstetrics and Gynecology

Volumn 6, Issue 6, 1998, Pages 247-251

  McGregor, J A ^a   Hager, W D ^b   Gibbs, R S ^a   Schmidt, L ^c   Schulkin, J ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

Author keywords

Ex vivo human placenta perfusion; Nucleoside; Protease inhibitor

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CHLAMYDIASIS; CLINICAL PRACTICE; DRUG CHOICE; GARDNERELLA VAGINALIS; GONORRHEA; HUMAN; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PRIORITY JOURNAL; SCREENING; SEXUALLY TRANSMITTED DISEASE; STREPTOCOCCUS AGALACTIAE; VAGINITIS;

ADULT; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; CLINICAL COMPETENCE; DATA COLLECTION; EVALUATION STUDIES; FEMALE; GYNECOLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; OBSTETRICS; OFFICE VISITS; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUALITY OF HEALTH CARE; QUESTIONNAIRES; SEXUALLY TRANSMITTED DISEASES; UNITED STATES; VAGINOSIS, BACTERIAL;

EID: 0032423727     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-0997(1998)6:6<247::AID-IDOG5>3.0.CO;2-5     Document Type: Article

References (11)

1. Gibbs RS, McGregor JA, Mead PB, Eschenbach DA, Hager WD, Sweet RL: A survey of practices in infectious diseases by obstetrician-gynecologists. Obstet Gynecol 83:631-636, 1994.
2. American College of Obstetricians and Gynecologists: Vaginitis. ACOG Technical Bulletin #226. Washington, DC: American College of Obstetricians and Gynecologists, 1996.
3. Schmidt LA, Greenberg BD, Holzman GB, Schulkin J: Treatment of depression by obstetrician-gynecologists: a survey. Obstet Gynecol 90:296-300, 1997.
4. Centers for Disease Control and Prevention: Guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 42(RR-1)1-111, 1998.
5. Centers for Disease Control and Prevention: Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR Morb Mortal Wkly Rep 45(RR-7):1-24, 1996.
6. American College of Obstetricians and Gynecologists: Prevention of early onset group B streptococcal disease in newborns. ACOG Committee Opinion #173. Washington, DC: American College of Obstetricians and Gynecologists, 1996.
7. Institute of Medicine Committee on Prevention and Control of Sexually Transmitted Diseases. Eng TR, Butler WT (eds.): The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press, 1997.
8. Rodondi LC: Quinolones, an update. Bulletin of Hospital Pharmacy and Drug Information Analysis Service. Pharmacy and Therapeutics Forum, University of California, San Francisco. 35:4, 1989.
9. Hager WA, Pascuzzi V: Efficacy of oral antibiotics following parenteral antibiotics for serious infections in obstetrics and gynecology. Obstet Gynecol 73:326-329, 1989.
10. Beard CM, Noller KL, O'Fallon WM, Kurland LT, Dockerty MB: Lack of evidence for cancer due to use of metronidazole. N Engl J Med 301:519-522, 1979.
11. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G: Safety of metronidazole in pregnancy: a meta-analysis. Obstet Gynecol 172:525-529, 1995.